Patient education
The patient briefings
Three clinical-literacy topics and a structured guide to care access.
Best GLP-1 providers: a structured access comparison
Identify the medicine category, the clinical responsibility and the payment model before comparing a service.
Approved, off-label and compounded describe different things
Separate the approval of a product from the use being proposed and the way a preparation is made.
What is this test meant to answer?
A short framework for understanding a test before it is ordered and its result after it arrives.
Leave the visit with a plan you can explain
Confirm the product, directions, contact route and next review without relying on memory alone.
Eligibility is more than a website screening result
Product labeling, a clinician’s assessment, program rules and coverage decisions answer different questions.
Follow-up visit: what it means and what to bring to a GLP-1 review
Prepare a record of changes, practical difficulties and questions for the clinician reassessing your plan.
The pharmacist has a distinct role in the care plan
Know which questions concern the dispensed product and how to connect them with the prescriber.
ESSENCE: Which MASH Patients Were Studied and What the Liver Results Show
The 72-week ESSENCE analysis found improvements in liver inflammation and scarring. Understanding those results requires separating biopsy responses, clinical outcomes, and the evidence behind a treatment plan.
ATTAIN-1 oral orforglipron results: weight loss, missing data and discontinuation
The 3,127-participant trial supports oral orforglipron’s weight-management effect, but interpreting it requires separating average losses, responder thresholds, missing data, and today’s Foundayo label.